rofecoxib has been researched along with Diabetes Mellitus, Type 2 in 2 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, we conducted a double-blind, randomized trial to evaluate the effects of celecoxib, rofecoxib, and naproxen on 24-hour blood pressure (BP) in patients with type 2 diabetes, hypertension, and osteoarthritis." | 5.11 | The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. ( Brabant, T; Fort, JG; Kivitz, A; Pitt, B; Simon, LS; Sowers, JR; van Ingen, H; Whelton, A; White, WB; Winer, N, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sowers, JR | 1 |
| White, WB | 1 |
| Pitt, B | 1 |
| Whelton, A | 1 |
| Simon, LS | 1 |
| Winer, N | 1 |
| Kivitz, A | 1 |
| van Ingen, H | 1 |
| Brabant, T | 1 |
| Fort, JG | 1 |
| Tewari, P | 1 |
| Nath, SS | 1 |
| Mazumdar, G | 1 |
1 trial available for rofecoxib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Blood Pressure Determi | 2005 |
1 other study available for rofecoxib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Increased prothrombin time and lactic acidosis: rofecoxib drug interaction with acenocoumarin and metformin.
Topics: Acenocoumarol; Acidosis, Lactic; Anticoagulants; Aortic Valve Stenosis; Cyclooxygenase 2 Inhibitors; | 2007 |